Integra LifeSciences (IART) PT Lowered to $13 at Wells Fargo
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $17.42 +1.04%
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Wells Fargo analyst Vik Chopra lowered the price target on Integra LifeSciences (NASDAQ: IART) to $13.00 (from $25.00) while maintaining a Equal Weight rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- CrowdStrike (CRWD) PT Raised to $235 at JPMorgan
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
